CAS: 1621375-32-3
| Marca | Datos del producto | Pureza | Rango de precios | Entrega estimada |
|---|---|---|---|---|
 | 4-(4-(2,4-二溴-1H-咪唑-1-基)噻唑-2-基)吗啉 REF: IN-DA01JGP0CAS: 1621375-32-3 | 99% | A consultar | Mar 15 Abr 25 |
 | VPC-14449 REF: TM-T24944CAS: 1621375-32-3 | 99.56% | 373,00 €~4.038,00 € | Mar 03 Jun 25 |
 | 4-(4-(2,4-Dibromo-1H-imidazol-1-yl)thiazol-2-yl)morpholine REF: 3D-WPC37532CAS: 1621375-32-3 | Min. 95% | - - - | Producto descatalogado |
4-(4-(2,4-二溴-1H-咪唑-1-基)噻唑-2-基)吗啉
CAS:1621375-32-3
Fórmula:
C10H10Br2N4OS
Pureza:
99%
Forma y color:
Solid
Peso molecular:
394.0855999999999
Ref: IN-DA01JGP0
| 10mg | 183,00 € | ||
| 25mg | 460,00 € | ||
| 50mg | 553,00 € | ||
| 100mg | A consultar |
Entrega estimada en Estados Unidos, el Martes 15 de Abril de 2025
VPC-14449
CAS:1621375-32-3
VPC-14449 is a selective androgen receptor DNA-binding domain (AR-DBD) inhibitor, useful in prostate cancer research.
Fórmula:
C10H10Br2N4OS
Pureza:
99.56%
Forma y color:
Solid
Peso molecular:
394.09
Ref: TM-T24944
| 1mg | 373,00 € | ||
| 5mg | 904,00 € | ||
| 10mg | 1.225,00 € | ||
| 25mg | 1.825,00 € | ||
| 50mg | 2.375,00 € |
Entrega estimada en Estados Unidos, el Martes 3 de Junio de 2025
4-(4-(2,4-Dibromo-1H-imidazol-1-yl)thiazol-2-yl)morpholine
CAS:1621375-32-3
Please enquire for more information about 4-(4-(2,4-Dibromo-1H-imidazol-1-yl)thiazol-2-yl)morpholine including the price, delivery time and more detailed …
Fórmula:
C10H10Br2N4OS
Pureza:
Min. 95%
Peso molecular:
394.09 g/mol
Ref: 3D-WPC37532
| 1mg | Descatalogado | Solicitar información | |
| 5mg | Descatalogado | Solicitar información | |
| 10mg | Descatalogado | Solicitar información | |
| 25mg | Descatalogado | Solicitar información | |
| 50mg | Descatalogado | Solicitar información |
